fk 633 and fibrinogen
fk 633 has been researched along with fibrinogen in 5 studies
Compound Research Comparison
| Studies (fk 633) | Trials (fk 633) | Recent Studies (post-2010) (fk 633) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 19 | 0 | 1 | 34,477 | 1,707 | 7,083 |
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Aoki, T; Cox, D; Motoyama, Y; Seki, J; Senzaki, K; Takasugi, H; Tanaka, A | 1 |
| Fujiwara, H; Tanaka, A | 1 |
| Aoki, T; Honda, S; Okubo, M; Seki, J; Senzaki, K; Takahashi, F; Takasugi, H; Tanaka, A; Tomiyama, Y | 1 |
| Cox, D; Seki, J | 1 |
| Arai, M; Honda, S; Kashiwagi, H; Kato, H; Kiyoi, T; Kosugi, S; Kurata, Y; Matsuzawa, Y; Tadokoro, S; Tomiyama, Y | 1 |
Other Studies
5 other study(ies) available for fk 633 and fibrinogen
| Article | Year |
|---|---|
The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIB/IIIA antagonist.
Topics: Animals; Bleeding Time; Blood Platelets; Cell Adhesion; Cells, Cultured; Coronary Circulation; Dipeptides; Dogs; Endothelium, Vascular; Fibrinogen; Fibrinolytic Agents; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins | 1996 |
Quantitative structure-activity relationship study of fibrinogen inhibitors, [[4-(4-amidinophenoxy)butanoyl]aspartyl]valine (FK633) derivatives, using a novel hydrophobic descriptor.
Topics: Dipeptides; Fibrinogen; Humans; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 1996 |
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Apyrase; Aspirin; Blood Platelets; Calcium; Cyclooxygenase Inhibitors; Dipeptides; Fibrinogen; Humans; Ion Transport; Peptide Fragments; Phenylacetates; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Signal Transduction; Sulfonamides; Thrombin; Thromboxane A2; Thromboxane B2; Tirofiban; Tyrosine | 1998 |
Characterization of the binding of FK633 to the platelet fibrinogen receptor.
Topics: Binding Sites; Binding, Competitive; Blood Platelets; Dipeptides; Fibrinogen; Fibrinolytic Agents; Humans; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex | 1998 |
A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
Topics: Adult; Allosteric Regulation; Amino Acid Substitution; Blood Platelets; Clot Retraction; Codon; Dipeptides; Female; Fibrinogen; Heterozygote; Humans; Ligands; Mutation, Missense; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Point Mutation; Polymorphism, Restriction Fragment Length; Protein Binding; Protein Structure, Tertiary; Recombinant Fusion Proteins; RNA, Messenger; Solubility; Structure-Activity Relationship; Thrombasthenia; Transfection | 2003 |